相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multiple SNPs Within and Surrounding the Apolipoprotein E Gene Influence Cerebrospinal Fluid Apolipoprotein E Protein Levels
Lynn M. Bekris et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Multiple-Reaction Monitoring-Mass Spectrometric Assays Can Accurately Measure the Relative Protein Abundance in Complex Mixtures
Andrew N. Hoofnagle et al.
CLINICAL CHEMISTRY (2012)
A rapid method for cross-species quantitation of apolipoproteins A1, B48 and B100 in plasma by ultra-performance liquid chromatography/tandem mass spectrometry
Michael E. Lassman et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Genetics of Alzheimer's disease: new evidences for an old hypothesis?
Jean-Charles Lambert et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Selected reaction monitoring applied to proteomics
Sebastien Gallien et al.
JOURNAL OF MASS SPECTROMETRY (2011)
Evaluation of Different Multidimensional LC-MS/MS Pipelines for Isobaric Tags for Relative and Absolute Quantitation (iTRAQ)-Based Proteomic Analysis of Potato Tubers in Response to Cold Storage
Yong Yang et al.
JOURNAL OF PROTEOME RESEARCH (2011)
On the Development of Plasma Protein Biomarkers
Silvia Surinova et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Apolipoprotein E in Alzheimer's disease and other neurological disorders
Philip B. Verghese et al.
LANCET NEUROLOGY (2011)
A pipeline that integrates the discovery and verification of plasma protein biomarkers reveals candidate markers for cardiovascular disease
Terri A. Addona et al.
NATURE BIOTECHNOLOGY (2011)
A targeted proteomics-based pipeline for verification of biomarkers in plasma
Jeffrey R. Whiteaker et al.
NATURE BIOTECHNOLOGY (2011)
Plasma apolipoprotein E and Alzheimer disease risk The AIBL study of aging
V. B. Gupta et al.
NEUROLOGY (2011)
Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants
Olgica Trenchevska et al.
PROTEOMICS (2011)
Systematic quantification of peptides/proteins in urine using selected reaction monitoring
Nathalie Selevsek et al.
PROTEOMICS (2011)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
The Bottleneck in the Cancer Biomarker Pipeline and Protein Quantification through Mass Spectrometry-Based Approaches: Current Strategies for Candidate Verification
Shalini Makawita et al.
CLINICAL CHEMISTRY (2010)
Simultaneous Quantification of Apolipoprotein A-I and Apolipoprotein B by Liquid-Chromatography-Multiple-Reaction-Monitoring Mass Spectrometry
Sean A. Agger et al.
CLINICAL CHEMISTRY (2010)
Platform for Establishing Inter laboratory Reproducibility of Selected Reaction Monitoring-Based Mass Spectrometry Peptide Assays
A. Prakash et al.
JOURNAL OF PROTEOME RESEARCH (2010)
A Quantitative Study of the Effects of Chaotropic Agents, Surfactants, and Solvents on the Digestion Efficiency of Human Plasma Proteins by Trypsin
Jennifer L. Proc et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Tyrosine-Lipid Peroxide Adducts from Radical Termination: Para Coupling and Intramolecular Diels-Alder Cyclization
Roman Shchepin et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Interlaboratory Study Characterizing a Yeast Performance Standard for Benchmarking LC-MS Platform Performance
Amanda G. Paulovich et al.
MOLECULAR & CELLULAR PROTEOMICS (2010)
Options and considerations when selecting a quantitative proteomics strategy
Bruno Domon et al.
NATURE BIOTECHNOLOGY (2010)
Hippocampal atrophy rates and CSF biomarkers in elderly APOE2 normal subjects
G. C. Chiang et al.
NEUROLOGY (2010)
Method for the simultaneous quantitation of apolipoprotein E isoforms using tandem mass spectrometry
Kristin R. Wildsmith et al.
ANALYTICAL BIOCHEMISTRY (2009)
Developing Multiplexed Assays for Troponin I and Interleukin-33 in Plasma by Peptide Immunoaffinity Enrichment and Targeted Mass Spectrometry
Eric Kuhn et al.
CLINICAL CHEMISTRY (2009)
Perspectives of targeted mass spectrometry for protein biomarker verification
Ruth Huettenhain et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Human APOE Isoform-Dependent Effects on Brain β-Amyloid Levels in PDAPP Transgenic Mice
Kelly R. Bales et al.
JOURNAL OF NEUROSCIENCE (2009)
Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications
Sheng Pan et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Clinical Quantitation of Prostate-specific Antigen Biomarker in the Low Nanogram/Milliliter Range by Conventional Bore Liquid Chromatography-Tandem Mass Spectrometry (Multiple Reaction Monitoring) Coupling and Correlation with ELISA Tests
Tanguy Fortin et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Multiple Reaction Monitoring-based, Multiplexed, Absolute Quantitation of 45 Proteins in Human Plasma
Michael A. Kuzyk et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Quantification of Cardiovascular Biomarkers in Patient Plasma by Targeted Mass Spectrometry and Stable Isotope Dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Targeted proteomic strategy for clinical biomarker discovery
Ralph Schiess et al.
MOLECULAR ONCOLOGY (2009)
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma
Terri A. Addona et al.
NATURE BIOTECHNOLOGY (2009)
Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease
Eric M. Reiman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Protein Quantitation through Targeted Mass Spectrometry: The Way Out of Biomarker Purgatory?
Steven A. Carr et al.
CLINICAL CHEMISTRY (2008)
Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry
Andrew N. Hoofnagle et al.
CLINICAL CHEMISTRY (2008)
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
David R. Riddell et al.
JOURNAL OF NEUROSCIENCE (2008)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
The interface between biomarker discovery and clinical validation: The tar pit of the protein biomarker pipeline
Amanda G. Paulovich et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution
Hasmik Keshishian et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Isotope-labeled protein standards
Virginie Brun et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Genetic heterogeneity of Azheimer's disease: Complexity and advances
Jean-Charles Lambert et al.
PSYCHONEUROENDOCRINOLOGY (2007)
Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: Patterns of linkage disequilibrium and disease/marker association
Chang-En Yu et al.
GENOMICS (2007)
Quantification of intermediate-abundance proteins in serum by multiple reaction monitoring mass spectrometry in a single-quadrupole ion trap
Shanhua Lin et al.
ANALYTICAL CHEMISTRY (2006)
Protein biomarker discovery and validation: the long and uncertain path to clinical utility
Nader Rifai et al.
NATURE BIOTECHNOLOGY (2006)
Apolipoprotein E structure: insights into function
Danny M. Hatters et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Quantitative mass spectrometric multiple reaction monitoring assays for major plasma proteins
L Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Four stage liquid chromatographic selection of methionyl peptides for peptide-centric proteome analysis: The proteome of human multipotent adult progenitor cells
K Gevaert et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Apolipoprotein gene E4 allele promoter polymorphisms as risk factors for Alzheimer's disease
GR Parker et al.
PSYCHIATRIC GENETICS (2005)
Neuronal specific regulatory elements in apolipoprotein E gene proximal promoter
MC Ramos et al.
NEUROREPORT (2005)
Human apolipoprotein E4 alters the amyloid-β 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model
JD Fryer et al.
JOURNAL OF NEUROSCIENCE (2005)
Mass spectrometric quantitation of peptides and proteins using stable isotope standards and capture by anti-peptide antibodies (SISCAPA)
NL Anderson et al.
JOURNAL OF PROTEOME RESEARCH (2004)
Cerebrospinal fluid β-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease:: The effect of APOE ε4 allele
T Sunderland et al.
BIOLOGICAL PSYCHIATRY (2004)
Combined association and linkage analysis applied to the APOE locus
M Beekman et al.
GENETIC EPIDEMIOLOGY (2004)
APOE ε3/ε4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis
H Fukumoto et al.
EXPERIMENTAL NEUROLOGY (2003)
Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS
SA Gerber et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The importance of plasma concentration in addition apolipoprotein E to its common polymorphism on inter-individual variation in lipid levels: results from Apo Europe
N Haddy et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2002)
Chromatographic isolation of methionine-containing peptides for gel-free proteome analysis -: Identification of more than 800 Escherichia coli proteins
K Gevaert et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Human and murine ApoE markedly alters Aβ metabolism before and after plaque formation in a mouse model of Alzheimer's disease
AM Fagan et al.
NEUROBIOLOGY OF DISEASE (2002)
Variation at the APOE-491 promoter locus is associated with altered brain levels of apolipoprotein E
SM Laws et al.
MOLECULAR PSYCHIATRY (2002)
Effect of APOE genotype and promoter polymorphism on risk of Alzheimer's disease
JC Wang et al.
NEUROLOGY (2000)
Apolipoprotein E serum concentration and polymorphism in six European countries: the ApoEurope Project
F Schiele et al.
ATHEROSCLEROSIS (2000)
Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
DM Holtzman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Measurement of apolipoprotein E (apoE) in cerebrospinal fluid
C Hesse et al.
NEUROCHEMICAL RESEARCH (2000)
Age-dependent decline in the apolipoprotein e level in cerebrospinal fluid from control subjects and its increase in cerebrospinal fluid from patients with Alzheimer's disease
R Fukuyama et al.
EUROPEAN NEUROLOGY (2000)
Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations - the ECTIM Study
JC Lambert et al.
HUMAN MOLECULAR GENETICS (2000)
分享论文
